Search Results - "Aydın,Mürüvvet Seda"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Comprehensive Assessment of Common Medical Problems in Adult Patients with Hemophilia A: A Single-Center Experience in Turkey by Aydın,Mürüvvet Seda, Çiftçiler,Rafiye, İnkaya,Ahmet Çağkan, Aksu,Salih

    Published in Gazi tıp dergisi (01-01-2022)
    “…Objective: Chronic age related medical problems and blood-borne viral infections may be overlooked by the clinicians in Hemophilia A, and likewise Hemophilia A…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    MPN-172 Is It Necessary to Evaluate Routine Hemostasis Tests in Myelofibrosis? by Aydın, Mürüvvet Seda, Kalaci Katayıfçı, Gaye, Ceran, Funda, Dağdaş, Simten, Özet, Gülsüm

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)
    “…Hematologic malignancies are one of the underlying diseases that frequently cause disseminated intravascular coagulation (DIC). Although the frequency of DIC…”
    Get full text
    Journal Article
  6. 6
  7. 7

    NEXT GENERATION SEQUENCING PRACTICES IN HEMATOLOGY: A RECENT EXPERIENCE OF A SINGLE CENTER by Muruvvet Seda AYDIN, Funda CERAN, Simten DAGDAS, Gulsum OZET

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Objective: Next-generation sequencing (NGS)-based technologies are  novel methodologies for the diagnosis, prognostic assessment and decision of individualized…”
    Get full text
    Journal Article
  8. 8

    Effectiveness and safety of therapeutic plasma exchange in neurological diseases: An 11‐year report from a tertiary care center by Korkmaz, Gulten, Dagdas, Simten, Saltoglu, Tugce, Ceran, Funda, Aydın, Muruvvet Seda, Bektas, Hesna, Subutay, Nese, Dilek, Imdat, Ozet, Gulsum

    Published in Therapeutic apheresis and dialysis (05-11-2024)
    “…Abstract Background Therapeutic plasma exchange has been a well‐known treatment method for many years and is widely available. It leads to the improvement of…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms by Bahcecioglu, Adile Begum, Etgul, Sezgin, Aslan, Tuncay, Aydın, Muruvvet Seda, Malkan, Umit Yavuz, Okay, Mufide, Ozdemir, Evren, Ciftciler, Rafiye, Goker, Hakan, Buyukasik, Yahya

    Published in Blood (02-12-2016)
    “…Introduction: Interferon (IFN-α) is frequently used in various hematologic neoplastic disorders either at failure of first-line treatment or as first-line…”
    Get full text
    Journal Article
  12. 12
  13. 13